Logo

CTCs

TellBio, ARUP Laboratories to Explore CTC Collection Platform for Cancer Research
Premium

ARUP hopes to use TellBio's platform for several applications in solid tumor types, including prostate and gynecological cancers.

TellBio Raises $5M in Series A Round, Inks Deals With Genetron, ARUP for Liquid Biopsy Platform

The startup's strategic agreements with Genetron Holdings and ARUP Laboratories will accelerate global deployment of its TellDx liquid biopsy platform.

Biocept Prepares for First FDA Foray With CSF Liquid Biopsy Brain Metastases Assay
Premium

The company has previously offered its liquid biopsy tests through an LDT model but sees the timing and the clinical niche as right for a regulatory bid in CSF testing.

Startup MiCareo Targets Rare Cell Isolation Market With Flow Displacement Instrument
Premium

The Taiwan-based startup aims to publish data showing the instrument's prognostic value in colorectal cancer, as well as launch a new version, by this summer.

Biocept Q4 Revenues Spike as COVID-19 Testing Continues to Soar, Core Cancer Tests Lag

The firm's fourth quarter revenues included $18.3 million in commercial test revenue, of which $17.6 million was attributable to COVID-19 tests.

Mar 25, 2021

Startup Tethis Targets Early-Stage Breast Cancer Detection With CTC Sample Prep Platform
Premium

Mar 24, 2021

Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform

Mar 23, 2021

CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test

Mar 18, 2021

Scienion, Gilupi to Develop Circulating Tumor Cell Analysis Workflow

Mar 17, 2021

Metabolic Marker Helps Identify Lung Cancer-Linked Circulating Tumor Cells
Premium

Mar 3, 2021

Deepcell Advancing AI-Driven Cell Morphology Tech for Single-Cell Genomics, Liquid Biopsy
Premium

Jan 21, 2021

OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay
Premium

Dec 18, 2020

BioView, Ruby Nanomed Form Circulating Tumor Cell Analysis Partnership

Dec 10, 2020

Menarini's CellSearch Shows CTCs' Potential to Predict Breast Cancer Prognosis, Treatment Response
Premium

Nov 19, 2020

Epic Sciences, USC Michelson Center Sign Licensing Agreement for Liquid Biopsy Research

Nov 13, 2020

Biocept Eyes Neuro-Oncology for Future Liquid Biopsy Growth as Testing Lags Amid COVID Pandemic
Premium

Nov 9, 2020

Savran Technologies to Target Breast Cancer Recurrence with Circulating Tumor Cell Platform
Premium

Oct 29, 2020

Epic Sciences, Predicine to Offer Liquid Biopsy Service for Biopharma Customers

Oct 9, 2020

Georgetown Team Sees Potential for Novel CTC Culture Method to Study Metastatic Cancer
Premium

Sep 28, 2020

Angle Files De Novo FDA Submission for CTC Collection Device in Breast Cancer

Sep 10, 2020

Epic Sciences, MSK Identify Potential Prostate Cancer Therapy Response Biomarker
Premium

Jul 10, 2020

Presence of cfDNA, CTCs Predicts Recurrence in Triple-Negative Breast Cancer

Jun 29, 2020

Creatv MicroTech Aims to Detect Patient Immune Cells for Cancer Drug Response Prediction
Premium

May 13, 2020

Biocept Q1 Revenues Up 41 Percent

May 7, 2020

Prospective Study Adds Evidence for CellMax Life Liquid Biopsy Utility in CRC Screening
Premium

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.